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Introduction
Fractional flow reverse (FFR) estimation became a standard in the assessment of intermediate lesions. The value of FFR ≤ 0.80 became a cut-off value to intervene, and such an approach was well documented to reduce the incidences of future major adverse cardiac events (MACE) [1] .
Fractional flow reverse assesses a functional impact of atheroma on the myocardial ischemia, but does not take into account the morphology of the lesion. Previous histological and intravascular imaging studies identified features of vulnerable plaques, which are prone to rupture. Post-mortem studies presented that thin fibrous cap atheroma (TCFA) covered rupture plaques [2] and in vivo optical coherence tomography (OCT) identified TCFA more frequently in ST elevation myocardial infarction (STEMI) patients [3] . The prospect study presented that lesions with plaque burden (PB) ≥ 70% and minimal lumen area (MLA) ≤ 4 mm 2 on intravascular ultrasound (IVUS) imaging increased the risk of MACE [4] . A high lipid burden assessed by intravascular near-infrared spectroscopy (NIRS) suggested increased the risk of future MACE [5] , and combined NIRS-IVUS imaging study presented its potential to detect TCFA [6] .
Given the results of histological and intravascular imaging, the question arose whether FFR assessment was sufficient to exclude intermediate lesions from intervention. With the following study, the intermediate lesion was assessed by the simultaneous OCT and combined NIRS-IVUS imaging together with FFR assessment. The aim of this study was to describe intermediate lesion characteristics in regard to their vulnerability and FFR results.
Methods
Study population
The current study employed intravascular FFR, OCT and combined NIRS-IVUS assessment of identical coronary intermediate lesions of the same patient. All imaging was performed during the same procedure. The study group was selected from patients referred for cardiac catheterization due to chronic stable coronary disease symptoms. Patients with renal failure (creatinine > 1.5 mg/dL), hemodynamic compromise, contrast allergy, aortoostial coronary artery lesions, and calcified lesions were excluded from the study. Intermediate lesions to assess by FFR were selected at the operator's discretion after the diagnostic angiogram. FFR, OCT, and NIRS-IVUS were performed under heparin anticoagulation (activated clotting time > 300 s) following intracoronary nitroglycerine (100-200 µm) administration.
NIRS-IVUS and OCT images were analyzed by the independent Core Laboratory (KCRI.org). Also, angiographic quantitative coronary analysis (QCA) was performed. Coronary lesions with incomplete and/or poor quality NIRS-IVUS or OCT scans were removed from the investigation (4 coronary lesions). Hence the ultimate analysis included 14 coronary lesions assessed in 13 patients.
The study was approved by to Local Bioethical Committee of Wroclaw Medical University in Poland, and all patients signed an informed consent before the procedure.
QCA measurements
Quantitative coronary analysis was performed offline using a validated CAAS QCA software (Pie Medical Imaging BV) for calculation of minimum lumen diameter and reference lumen diameter (the average of the reference lumen diameter proximal to the lesion and reference lumen diameter distal to the lesion). These data were used to calculate % diameter stenosis [(minimal lumen diameter/reference lumen diameter) × 100%]. Also, complete coronary segment morphology characteristics were evaluated according to the American Heart Association/American College of Cardiology classification.
FFR measurements
Fractional flow reverse measurements were performed using ILUMIEN™ OPTIS™ PCI Optimization™ System (St. Jude Medical). The adenosine was applied intracoronary to a maximal dose of 140 µg for the left coronary artery and 100 µg for the right coronary artery. All FFR measurements were performed after the intracoronary injection of nitroglycerine.
OCT image acquisition
The commercially available ILUMIEN™ OPTIS™ PCI Optimization™ System (St. Jude Medical) was used for OCT image acquisition. The tip of the 2.7 Fr. OCT catheter was placed at least 15 mm distally to the imaging target lesion. OCT image acquisition was then performed by the hand injection of contrast (Visipaque; total volume 12-20 mL) and simultaneous OCT catheter pullback at 20 mm/s. Each OCT catheter pullback imaged a total of 54 mm of the vessel.
OCT image analysis
Optical coherence tomography image analysis scrutinized serial cross-sectional images of the vessel, at 1 mm intervals, using the LightLab Imaging Offline Review Station. Plaque composition was analyzed according to previously validated criteria for OCT [7] . In brief, signal rich homogenous plaques were classified as fibrous, signal-poor regions with diffuse borders were classified as lipid and signal-poor regions with well-defined borders were classified as calcified plaques. The magnitude of lipid content was measured as the circumferential extent of lipid in OCT cross-sectional images and expressed in degrees (OCT lipid arc, o ). When lipid arc was stretched > 90°, the OCT lipid-rich plaque was detected. Fibrous cap thickness was derived by measuring the thinnest signal rich zone separating the lipid content from the vessel lumen (µm). The thinnest part of the fibrous cap was measured three times and its average was defined as the fibrous cap thickness. OCT-defined TCFA was defined as a lipid-rich plaque with fibrous cap thickness < 65 µm. Also, the presence of both plaque rupture and/or luminal thrombus was noted during OCT analysis.
The cross-sectional area (CSA), minimumand maximum diameter of the vessel was measured every 1 mm. The smallest CSA in one segment was taken as the OCT-defined minimal CSA. The OCT reference lumen area was estimated as the largest CSA within 10 mm proximally or distally to the minimal lumen CSA in the scanned coronary segment.
Combined NIRS and grey-scale IVUS image acquisition
Combined NIRS and gray-scale IVUS image acquisition was performed using the commercially available TVC Imaging System™ with the 2.4 Fr. TVC Insight Catheter (InfraReDx). The tip of the TVC catheter was positioned at least 10 mm distal to the imaging target lesion. Subsequently, the automated pullback was started with at 0.5 mm/s (240 rotations/min) until the TVC catheter entered the guiding catheter.
NIRS image analysis
The raw spectra of NIRS estimate the probability of the presence of an atherosclerotic lipid core and measurements are displayed as a chemogram -a digit code NIRS map [6] . The NIRS map analysis allows calculation of lipid core burden index (LCBI) in 4 mm pullback compartments.
NIRS map analysis was performed using QIVUS Medis software.
Gray-scale IVUS image analysis
Quantitative gray-scale IVUS measurements were performed every 1 mm in scanned coronary segments using QIVUS Medis software (2.1 version). Cross-sectional images were quantified for lumen CSA, external elastic lamina (EEM) CSA, plaque and media CSA and plaque burden. Plaque and media CSA were calculated as the difference between EEM CSA and lumen CSA. Plaque burden was calculated as plaque and media CSA divided by EEM CSA × 100 (%) at the minimal CSA site.
The IVUS reference lumen area was estimated as the largest CSA within 10 mm located proximally or distally to the minimal lumen CSA in one analyzed coronary segment. The reference EEM CSA was calculated as an average of the proximal and distal EEM CSA with the smallest plaque burden, but not higher than 50%. If either the proximally or distally evaluated plaque burden was ≥ 50%, then the proximal or distal EEM CSA with the least plaque burden served as reference.
A lesion was defined as the region between proximal and distal EEM reference sites or as the region between either proximal or distal EEM reference sites or a side branch delimiting the assessed coronary segment. Remodeling index (RI) was calculated by dividing EEM CSA at the site of minimal lumen CSA by reference EEM CSA. Lesions with RI ≤ 0.95 were defined as negatively remodeled, while those with an RI ≥ 1.05 were defined as positively remodeled. An RI between these values was taken as a non-remodeled vessel.
In every lesion, a lumen vessel volume and EEM volume was calculated based on Simpson's rule (mm 3 /cm). These data were used to estimate plaque volume (EEM volume -vessel volume, mm 3 /cm) and % plaque volume [100 × (plaque volume) / EEM volume, %].
Co-registration of NIRS, gray-scale IVUS and OCT
During the combined NIRS-IVUS pullback, anatomical landmarks were imprinted on the chemogram and bookmarked on IVUS imagesi.e. fiducial points, minimal vessel CSA and side branches. Those landmarks allowed matching of OCT images to corresponding sections of NIRS map, IVUS images, and the coronary angiogram. Such co-registration allowed simultaneous judgment of LCBI values, IVUS measurements and 
The identification of vulnerable lesions
According to the previously published studies, the following vulnerable lesions were identified by OCT and NIRS-IVUS imaging. OCT-defined TCFA as described above, IVUS vulnerable plaque defined as lesion with PB > 70% and MLA < 4 mm 2 (PROSPECT study) [4] , and NIRS-IVUS TCFA described previously as LCBI 4 mm > 265 with simultaneous positive RI of the vessel [6] and lesions with LCBI 4 mm > 400, which was the threshold of lipid burden for observed culprit STEMI lesions [8] .
Statistical analysis
Kolmogorov-Smirnov analysis assessed the obtained data distribution. For normally distributed values data are presented as mean with standard deviation, for non-normally distributed values data were presented as median with interquartile intervals (IQR, 25 percentile, 75 percentile). Data analysis was performed using Medcalc software (16.8.4).
Results
Patient characteristics
There were 13 patients (8 male; 61%) with stable coronary artery disease enrolled into the study with a mean age 62.84 ± 6.03 years and with a mean body mass index 27.08 ± 2.42. Eleven (85%) patients suffered from hypertension, 6 (46%) had hyperlipidemia, 2 (15%) were diabetic, and 7 (54%) were smokers. All patients received aspirin, 11 (85%) received thienopyridine. Both diabetic patients were using insulin injection.
QCA analysis
The reference lumen diameter was 2.9 (IQR 2.29, 3.39) with MLD 1.44 (IQR 0.96, 1.96) and lesion length 7.06 mm (IQR 6.34, 12.64). The median % DS was 52% (IQR 33, 61). One lesion was classified as B2/C; the other 12 lesions were classified as A/B1.
FFR assessment
Two lesions were found to have FFR < 0.80 (0.65 and 0.76). The other 11 lesions had mean FFR 0.88 ± 0.049. Two FFR positive lesions were located in the proximal and medial segment of the left anterior descending artery (LAD). FFR negative segments were located as follows: 4 in proximal LAD, 4 in medial LAD, 1 in distal left main, 1 in proximal right coronary artery and 1 in the ramus intermedius. Only FFR positive lesions were stented.
NIRS-IVUS imaging
For the reference segment of the vessel, EEM CSA was 15.59 ± 6.81 mm 2 
OCT and NIRS-IVUS imaging in detection of plaque vulnerability
Two lesions with FFR ≤ 0.80 had PB > 70% and MLA < 4 mm 2 , but none of these two lesions were identified as OCT defined TCFA or NIRS-IVUS possible TCFA. Among the other 11 lesions with FFR > 0.80, 8 were identified as OCT-defined TCFA, 4 had a PB of more than 70%, 6 had MLA less than 4 mm 2 , 2 had both PB > 70% and MLA < 4 mm 2 , 3 were identified as NIRS-IVUS possible TCFA, and 4 had LCBI > 400 mm (Table 1, Fig. 1 ).
Discussion
It remains challenging to identify vulnerable plaques which rupture and cause an acute coronary occlusion. Previous intravascular imaging studies focused on morphological patterns of atheroma to detect such lesions, but it did not translate to its identification on daily clinical practice. Furthermore, the introduction of FFR assessment simplified the operator's decision by providing a selection of lesions between those to treat and Cardiology Journal 2018, Vol. 25, No. 2 those to be left untouched. Such an approach was strongly indicated by clinical results and significantly improved patient outcome [9, 10] . Nevertheless, it pushed aside lesion morphology assessment, which identifies vulnerable plaques. The presented proof of concept study showed that some of FFR negative lesions still posed traits of vulnerability.
Ischemic lesions increase by 12 times the risk of death at 5 year follow-up [11] , and treatment of such lesion decreases MACE [12] . On the other hand, not only lesion functionality increases the risk of future MACE, but lesion morphology as well. Analysis from the PROSPECT study showed that lesions with PB ≥ 70% and MLA ≤ 4 mm 2 increases 3 times the risk of MACE at 3.4 year follow-up, respectively [4] . The present observations suggested that despite FFR negative results such IVUS vulnerable lesions may remain left untreated and thus, may pose a risk to patients.
Fractional flow reverse positive lesions had more lipids [13] , presented higher PB and smaller MLA [14] . Furthermore, the length of the plaque and its volume positively correlated with FFR results as well [15] . Alltogether this suggests that most of the vulnerable intermediate lesions are already treated based on FFR measurements anyway, but it should be noted that a high consternation of necrotic core was also observed in FFR negative lesions [14] . Clinical observations presented similar clinical outcomes for the coronary lesion discrimination by IVUS or FFR [16] , despite the limited utility of IVUS measurements to guide intervention [17] . Similar clinical outcomes for IVUS and FFR guided interventions suggest that some of IVUS guided intervention were preformed in FFR-negative vulnerable lesions, which brought benefit to patients.
Previous OCT analysis presented that nonculprit lesions exposed traits of plaque vulnerability for both acute and stable patients with a higher prevalence of TCFA in obese patients [18, 19] . With the presented study we have also observed OCT-defined TCFA in FFR negative lesions. Such atheroma also prevailed in non-culprit lesions in STEMI patients [3] and was more frequently found in cadavers who died from myocardial infarction [2] . Interestingly, recent studies presented that morphological characteristics of plaques assessed by OCT were not independently associated with FFR [20] . The presented observation extended these observations and confirmed the presence of OCT-defined TCFA in FFR negative lesions. Therefore, the first prospective COMBINE study has been launched to detect whether OCT-defined TCFA observed in FFR negative lesions of diabetic patients increased the risk of future MACE [21] . Recently, the intravascular NIRS has been introduced into coronary artery assessment, which provides a very simple and quantitative analysis of lipid burden within the assessed lesions. The in vitro study suggested its potential to detect vulnerable plaques [22] . Furthermore, clinical observation advocated that it might identify vulnerable plaques [6, 8] and patients at risk of MACE [5] . Previously NIRS presented a high lipid burden in non-culprit lesions, but the assessment of lesion morphology by NIRS against FFR lesion was not performed previously [23] . With the present study, it was shown that some of the FFR-negative lesions pose traits of vulnerability, as detected by LCBI alone or combined NIRS-IVUS analysis.
This proof of concept study confirmed that 3 leading intravascular modalities might detect different traits of vulnerability in FFR negative lesions, which warrants further observation as to whether such lesions requires intervention. The implantation of drug eluting stent into vulnerable lesions replaces the risk of plaque rupture with risk of in-stent restenosis. Therefore, the concept emerged that TCFA might be covered with bioresorbable vascular scaffold bioresorbable vascular scaffold to thicken the fibrous cap of the lipid-rich plaque and thus to prevent its future rupture [24] , but the latest results on bioresorbable vascular scaffold implantation strongly suggestsrefraining from their reckless use. On the other hand, such lesions may be left untouched and treated conservatively. The application of aggressive lipid-lowering therapy decreased lipid content within the plaque and decreased its vulnerability [25, 26] .
Limitations of the study
It was an observational study involving a very small group of patients. Secondly, it mostly referred to FFR-negative lesions, which biased final observations. The lack of patient follow-up limits the strength of the results.
Conclusions
The FFR-negative lesions pose traits of vulnerability as assessed simultaneously by IVUS, OCT and NIRS imaging.
